Sunday, January 6, 2019

(LML) Missed lepromatous cases

Leprosy Mailing List – January 6,  2019
Ref.:  (LML) Missed lepromatous cases
From:  Joel Almeida, London and Mumbai


Dear Pieter,

Congratulations to the Indian Central Leprosy Division for a careful investigation of missed cases in Salaunikhurd village, Bilaigarh Block, Chhattisgarh state. (1) 
The annual new case detection rate, in the Block, which had hovered around 30 per 10000 persons/yr until 2015 has risen to over 100 per 10000 persons/yr since then.
Multiple cases in one family, all with infiltrated skin and even some nodules, escaped detection during case detection campaigns. A careful investigation was carried out to understand what led to this. A team of experts visited the village.

It turns out that the symptoms were not worrisome and the patients hoped for self-cure. The duration of symptoms before diagnosis was between about 1 to 2 years. The patients are described as having "de novo MB" leprosy. Presumably, no patches ever appeared.Neither the patients nor the village health personnel were aware that this was leprosy, and stigma was not a clear explanation for the delay in seeking diagnosis. The family had a low income and family members had to migrate as seasons changed (presumably in order to survive by finding some income). The knowledge about leprosy among the village health personnel and those at the primary health centre was found to require improvement.

What can we conclude from this excellent investigation, apart from the fact that the Central Leprosy Division deserves congratulations for its meticulous approach to continuous improvement at the frontlines?

1) We are teaching health personnel to detect every kind of leprosy except lepromatous leprosy, the kind that is most responsible for the spread of M. leprae. Denying skin smear services to front-line personnel is like sending firemen to fight fires but with blindfolds on.
We need urgently to rebuild skin smear services, otherwise we will keep failing to detect lepromatous cases. Then we will have steadily more examples of the annual new case detection rate rising to over 100 per 10000 persons/yr despite all our worthy efforts.

2) Low income forces people to move around in search of work. Persons with anergy are fertile soil for M. leprae. One person with anergy can harbour more M. leprae than tens of thousands of patients with well-defined patches. A patient with anergy remains susceptible to reinfection if treatment is prematurely withdrawn. This is particularly important in villages such as Salaunikhurd, where sources of M. leprae are abundant. 
Then, through no fault of their own, unprotected patients with anergy tend to spread as many M. leprae as do tens of thousands of untreated persons with self-limiting forms of leprosy. Withdrawing treatment prematurely from patients with anergy is like sending the fire brigade home before the fire is extinguished.
Infectious diseases are like a fire. M. leprae are particularly dangerous because they cause few symptoms or signs in persons with anergy. The fire is hidden.  
Our failure reliably to detect patients with lepromatous leprosy and then to protect them against reinfection is like a huge but avoidable hole in our fire barrier. We can do better.

3) Well defined skin patches are often a sign that the infection has been contained. By contrast, the barely perceptible diffuse infiltration of early lepromatous leprosy easily can be missed.
Health personnel naturally gravitate to clearly visible patches, especially if they are denied the skin smear services that can confirm subtle signs of early lepromatous leprosy. It is like firemen focusing largely on smoke because subtle smouldering flames are hidden.
Since the early 2000s we have been discouraging skin smear services. That is why M. leprae continue to flourish in places like Salaunikhurd village, unnecessarily damaging human limbs, eyes and lives. The damage is avoidable, but we have to become builders of competent skin smear services once again.
The more quickly we detect hidden lepromatous leprosy, and the more we ensure protection against reinfection, for patients with anergy, the smaller the risk of the endemic flaring up as happened in Salaunikhurd village.

4) There is no substitute for continuous improvement at the frontlines. We have grown somewhat isolated from the realities of leprosy, and the clues that are continually available at the frontlines. That's why it's so important to invite in a new generation of leprosy workers in the endemic countries. 
We need to enlarge our horizons beyond past habits and past errors by understanding more clearly what is really happening between M. leprae, anergic patients, other patients, the community and the environment. Our minds need to be open to improved approaches.

The Indian Central Leprosy Division shows how important it is to open our eyes especially to unexpected failures (and unexpected successes, where reliable investigation confirms that). Then we can make continuous improvement a reality at the frontlines. Congratulations to the Indian CLD for this exemplary investigation.
I intend to compliment the relevant leaders in India for this exemplary work.

Joel Almeida

Reference
1) Central Leprosy Division, India. Epidemiological investigation of multiple cases occurring in one family in village Salaunikhurd. NLEP newsletter Vol III, Issue 3, July – Sept 2018



LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << editorlml@gmail.com

(LML) New Neuropathic Limb Care book from Dr Grace Warren

Leprosy Mailing List – January 6,  2019

Ref.:  (LML) New Neuropathic Limb Care book from Dr Grace Warren
From:  Jannine Ebenso, Brentford, UK


Dear LML readers,

Dr Grace Warren has updated her book  Neuropathic Limb Care.

The book was launched on 15 November and can be purchased directly from the Honeysett Press website.  https://www.honeysettpress.com/ 

Warm regards
Jannine

Jannine Ebenso

Head of Quality Assurance
The Leprosy Mission International, 80 Windmill Road, Brentford, Middlesex, TW8 0QH
T: +44 (0)7879647895  E:jannine.ebenso@leprosymission.org 
S: jannine.ebenso2008 W: www.leprosymission.org



LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << edit

Saturday, January 5, 2019

(LML) Early detection is the critical part

Leprosy Mailing List – January 5,  2019
Ref.:    (LML) Early detection is the critical part
From:  Francesca Gajete, Manila, Philippines

Dear Pieter,

We do agree with Professor Cairn Smith that early detection and treatment is a very crucial component of leprosy control program particularly in countries such as the Philippines where leprosy is no longer considered a public health problem and has less priority among NTDs. Yet we still find cases of Grade 2 Disabilities in some pocket areas wherein case finding is no longer considered by program managers.

We have been pushing with the academe particularly among Medical, Nursing, Medical Technology and Midwifery schools to include the Series 1 & Series 2 e-Learning Modules in Leprosy developed by the NLCP for GLP in 2012.

It is with high hopes that this subject be discussed at the plenary as a continuum of the Bangkok Declaration during the 20th International Leprosy Conference in Manila, Philippines, September 2019

With best regards,

Dr Francesca Cando Gajete
Philippines

LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << editorlml@gmail.com

(LML) Early detection is the critical part

Leprosy Mailing List – January 5,  2019
Ref.:    (LML) Early detection is the critical part
From:  Arry Pongtiku, Papua, Indonesia

Dear Pieter,
Firstly, wishing all of you the best in the new of 2019 with healthy, prosperous, happy, miraculous life and more for help people.

Thank you very much for Prof. Cairns Smith posting LML on 4 January 2019 about early detection is the critical part. I would like to add. It is indeed the propose of leprosy program not only to cure patients but also to cut transmission and to reduce stigma. It is the essence of early case detection. Treatment is significant/the best for prevention of leprosy.

In order to get the world free of leprosy, active case finding should be done and more health promotion to increase awareness. Our experience with role model leadership to go for surveys and in remote areas we detected more new cases of leprosy. If we are active we find more cases, if we are quiet we harvest a fake elimination. Health education campaigns used social media/technology to increase awareness people to come to health centres voluntary (passive case detection)

I once supported a study proactive health seeking behaviour for detection HIV in Paniai, Papua. We used promotion/campaign with local wisdom/cultural approach to the community, and the health provider went to community, and closer to them we detected more HIV patients (53 times increase in detection). Indonesia, in one hand are introducing an innovation for Knock Door; knock people houses for proactively detecting TB cases and on the other hand combined with TOSS (detection, treatment, and ensure finishing therapy).

Early case detection and treatment are cost effective strategies for leprosy. Some struggles are faced among which not infrequently limitation of MDT supply or out-of-stock altogether. We also need training and on the job training for leprosy health workers and to start introducing leprosy during their study. Early cases of leprosy may be more difficult to diagnose than the late stages. Leprosy is a great imitator. We need to give the health workers a handy book (atlas, illustrative book for those people in front lines). Some people ignore about patch/painless patches in his or her body because it does not disturb their daily life. DDS allergy must be aware after one- or two-months treatment.

Bio molecular studies for early case detection of leprosy/without symptoms are done. Furthermore, prevention through BCG immunization is cheap and applicable tool.

Leprosy should be a part of poverty alleviating strategies and human rights. More commitments including budget are needed. Integrated programs should be done where limited budget, limited staff and geographical constraints are faced. Motivation and inspiration should be tirelessly always in place. It is probably easier working in high endemic areas of leprosy, rather than low endemic areas where leprosy maybe forgotten.

Thank you so much,

Salam,

Arry PongtikuMD, MHM, PhD
Papua, Indonesia

LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << editorlml@gmail.com

Friday, January 4, 2019

(LML) Early detection is the critical part

Leprosy Mailing List – January 4,  2019
Ref.:    (LML) Early detection is the critical part
From:  Cairns Smith, Aberdeen, Scotland

Dear colleagues,

Early detection and treatment has been the basic strategy for leprosy control for the past 70 years.  Multidrug therapy (MDT) has proved a robust treatment since 1982 with minimal reported relapses.  Early detection is the critical component of the leprosy control strategy that prevents disability and transmission irrespective of the type of MDT used.  Surveys repeatedly show many people affected by leprosy are not diagnosed and treated, and many new patients have developed nerve damage by the time they are detected.  We now need to focus much more on promoting early detection.

Cairns Smith

W Cairns S Smith OBE, MD, MPH, PhD
Emeritus Professor of Public Health,
School of Medicine and Dentistry,
University of Aberdeen,
Polwarth Building,
Foresterhill,
Aberdeen AB25 2ZD,
Scotland, UK

Email: w.c.s.smith@abdn.ac.uk

Wednesday, January 2, 2019

(LML) NLEP Newsletter Vol. III Issues 2 and 3

Leprosy Mailing List – January 2,  2019
Ref.:    (LML)  NLEP Newsletter Vol. III Issues 2 and 3
From:  Anil Kumar, New Delhi, India


Dear colleagues,

Greetings from CLD,.
We are to please to share NLEP Newsletter Vol. III Issue 3 and Vol. III Issue 2 which may be seen on the following link 
I hope that you will find newsletter useful and look forward to your feedback.

Best regards,
Dr. Anil Kumar
DDG(L)


LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/de428932-1b5a-4dd3-a838-aa2d09b0c582%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

(LML) WHO Goodwill Ambassador’s Newsletter No. 92 Issue


Leprosy Mailing List – January 2,  2019
Ref.:    (LML) WHO Goodwill Ambassador's Newsletter No. 92 Issue
From:  Takahiro Nanri, Tokyo, Japan


Dear Dr Schreuder and Friends,

Warm greetings from Sasakawa Memorial Health Foundation in Tokyo.

We have uploaded our latest edition of "WHO Goodwill Ambassador's Newsletter No.92 Issue" to our website.  Please visit: https://www.smhf.or.jp/e/ambassador/  to obtain electronic version of this issue.

In this issue we feature articles about ...
 A recent conference sets leprosy history studies on an exciting new path.
-       A NEW APPROACH
 Tokyo Albinism Conference touches on some familiar themes for leprosy.
 On his latest visit to Indonesia, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa is encouraged to see the government take a multi-sectoral approach to tackling the medical and social dimensions of the disease.
-       MAKING A DIFFERENCE
 10-year trend characterized by slow but steady decline.
We have been carrying out a survey of our readers and would love to hear from you. The survey is available in English and Japanese. To those who select the English questionnaire, feel free to answer the questions in your own language if you prefer. Hope you could make a short time to fill in! It only takes 5 minutes!!         https://goo.gl/forms/tnndeLQrQaJSzD3i2
We hope you enjoy our latest Newsletter, and Wishing you a very great New year 2019!!

Takahiro NANRI, Ph.D.
 Executive Director
 Sasakawa Memorial Health Foundation
*********************************************************
https://blogger.googleusercontent.com/img/proxy/AVvXsEjm6yObcQBRDsET8KGx0zJvKEKV2f08e1Uf7vrULf4NmlMPUtHw72c8TFj84irSZ40zJPneKqNDoAB4f0u-fX8FFbA9JVwwrgQTV1m5v6_bd5Lysfj8ef4ssDW9J5yqh436vuF2OcZ4ox8Ps6ZyrnR8-4Pnsj-vUaDnfgVO=s0-d-e1-ftSasakawa Memorial Health Foundation
Tel03-6229-5377 
Fax03-6229-5388
email: smhf@tnfb.jp
visit our website at http://www.smhf.or.jp/
****************************************


LML - S Deepak, B Naafs, S Noto and P Schreuder
Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To post to this group, send email to leprosymailinglist@googlegroups.com.
Visit this group at https://groups.google.com/group/leprosymailinglist.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/866f9370-73e3-4ec6-8854-6e76058db6aa%40googlegroups.com.
For more options, visit https://groups.google.com/d/optout.